State Of Alaska, Department Of Revenue Arcus Biosciences, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 40,322 shares of RCUS stock, worth $412,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,322
Previous 37,288
8.14%
Holding current value
$412,494
Previous $292,000
11.99%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RCUS
# of Institutions
201Shares Held
62.3MCall Options Held
116KPut Options Held
116K-
Black Rock Inc. New York, NY9.76MShares$99.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.69MShares$68.4 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA5.13MShares$52.5 Million0.28% of portfolio
-
State Street Corp Boston, MA3.7MShares$37.8 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.87MShares$29.3 Million0.06% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $738M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...